Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

9.0%

6 terminated/withdrawn out of 67 trials

Success Rate

90.8%

+4.2% vs industry average

Late-Stage Pipeline

76%

51 trials in Phase 3/4

Results Transparency

47%

28 of 59 completed trials have results

Key Signals

1 recruiting28 with results

Enrollment Performance

Analytics

Phase 3

28(43.8%)

Phase 4

23(35.9%)

Phase 2

6(9.4%)

Phase 1

5(7.8%)

N/A

2(3.1%)

64Total

Phase 3(28)

Phase 4(23)

Phase 2(6)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (67)

Showing 20 of 67 trials

NCT00232687Phase 4Completed

A Switch Study of BMS-337039 in Schizophrenic Out-patients

Role: collaborator

NCT00095758Phase 3Completed

A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder

Role: collaborator

NCT00277212Phase 4Completed

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Role: collaborator

NCT00337571Phase 3Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Role: collaborator

NCT00332241Phase 3Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

Role: collaborator

NCT05190744Phase 2Completed

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Role: collaborator

NCT01246765Recruiting

National Pregnancy Registry for Psychiatric Medications

Role: collaborator

NCT03063944Phase 1Completed

STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy

Role: collaborator

NCT02237417Phase 4Completed

Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

Role: collaborator

NCT01182415Phase 2Completed

High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

Role: collaborator

NCT02476409Phase 4Completed

Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders

Role: collaborator

NCT03418675Phase 2Completed

Brexpiprazole in Borderline Personality Disorder

Role: collaborator

NCT01131169Phase 2Completed

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Role: collaborator

NCT02360319Phase 4Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

Role: collaborator

NCT02538016Not ApplicableCompleted

TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

Role: collaborator

NCT02183792Phase 4Completed

Aquaresis Utility for Hyponatremic Acute Heart Failure Study

Role: collaborator

NCT02472652Phase 4Terminated

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Role: collaborator

NCT03427892Phase 4Completed

Brexpiprazole for Bipolar Depression